A Mission to Pursue the Unsolvable

The Frederick National Laboratory is meeting the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

Conference: Study on blood tests to guide cancer treatment to be presented at 2023 ASCO Annual Meeting

Blood-based tests that identify cancer markers may offer a non-invasive way to determine if a patient is a candidate for...
Drug Development

A single dose of HPV vaccine may provide adequate protection

A growing body of evidence suggests that a single dose of vaccine against cancer-causing human papilloma virus (HPV) may...
Cancer Research

Awarded for 2023-2024 fiscal year

Three projects awarded LDER funding to explore innovations

Each year, the Frederick National Laboratory offers its scientists an opportunity to compete for funding to conduct the...
In Person Event Jun 5-8, 2023

Booth #3575

Symposium: Meet us at BIO International Convention

Representatives from our Center for Innovation and Strategic Partnerships will be attending the BIO International Convention…
Data Science

Study Explores Type 1 Diabetes Vaccine

A research collaboration has made early progress toward a potential vaccine for type 1 diabetes, a long-sought goal for an...

Investigating the Immune Response to SARS-CoV-2

A new test detects exposure to viruses that cause COVID-19 and their relatives. Research using it could aid efforts to...
Clinical Research

Vaccine tested for malaria and other mosquito-borne diseases

A research group that includes scientists from the Frederick National Laboratory for Cancer Research has shown that an...
What is this?

Tissue slide ablated with a Fluidigm Hyperion Imaging System that performs high-dimensional proteomics analysis of fresh-frozen tissues, tissue microarrays, smeared and formalin-fixed cells, and paraffin-embedded tissue. The Imaging Mass Cytometry Laboratory generated this image as part of their work providing cancer researchers with high-dimensional imaging analysis of tumor tissue samples at subcellular resolution.



The Serological Sciences Network, or SeroNet, is a collaboration to enhance understanding of the immune response to the novel coronavirus, SARS-CoV-2. SeroNet supports research projects in basic and applied serological research related to COVID-19 and increasing the nation’s serological testing capacity.
U.S. SARS-CoV-2 Serology Standard requests from industry, government and academic laboratories worldwide.

Center for Initiatives and Strategic Partnerships

We bring the Frederick National Laboratory’s distinct capabilities to the broader research community to help solve urgent problems in biomedical research.
Cooperative Research and Development Agreements and CRADA amendments to enable and extend research projects between FNL scientists and external investigators.

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.